Sentrimed, Inc.

New Filing

CIK: 0002014313·Biotechnology·DELAWARE·Filed: May 13, 2026

Total Offering

$1,000,000

Amount Sold

$250,000

Investors

1

First Sale

May 8, 2026

Offering Details

Type: Debt, Security to be Acquired
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2023
Non-Accredited Investors: No

Related Persons

Name	Role
William Ragatz
Bradley Galer
Jack Goldberg
Mari Rhodehamel Yin
Gary Goldberg
Arye Rosen
Christopher Leonard
Tabbetha Dobbins

Company

Sentrimed, Inc.

107 GILBRETH PARKWAY

MULLICA HILL, NJ, 08062

856-651-7140

SEC Filing

0002014313-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.